Naomi Ohbayashi
Naomi Ohbayashi publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Dupuytren's Contracture and Treatments.
- World rank
- #5,217,222 of 7,710,434 ranked researchers
- Rank in Japan
- #169,712 of 383,136
- Works
- 18
- Citations
- 481
- Citations per work
- 26.7
What does Naomi Ohbayashi research?
Naomi Ohbayashi's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (28%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences736.2%
- Everything else636.1%
- Health Sciences527.7%
- Medicine527.7%
- 1Molecular Biology32% of their works
- 2Radiology, Nuclear Medicine and Imaging8% of their works
- 3Oncology8% of their works
- 4Rheumatology6% of their works
- 5Biochemistry4% of their works
- 6Pharmacology4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Dupuytren's Contracture and Treatments
- Viral Infectious Diseases and Gene Expression in Insects
- Ubiquitin and proteasome pathways
- Plant biochemistry and biosynthesis
- Protein purification and stability
- HIV Research and Treatment
Which keywords describe Naomi Ohbayashi's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Collagenase Clostridium Histolyticum and Fasciectomy.
- Terpenoid Biosynthesis
- Protein Aggregation
- Mammalian Cells
- HIV
- AIDS
- Fasciectomy
- Cancer
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Collagenase Clostridium Histolyticum
- Glycans
- Biopharmaceuticals
- Isoprenoid Pathway
- Proteasome
- Recombinant Protein
- Ubiquitin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Glycosylation93 topics
- Monoclonal Antibodies62 topics
- Therapeutic Antibodies62 topics
- Antibody Engineering41 topic
- Fc Receptors41 topic
- Cancer31 topic
- Collagenase Clostridium Histolyticum31 topic
- Fasciectomy31 topic
- Glycans31 topic
- AIDS21 topic
- Biopharmaceuticals21 topic
- HIV21 topic
- Isoprenoid Pathway21 topic
- Mammalian Cells21 topic
- Proteasome21 topic
- Protein Aggregation21 topic
- Recombinant Protein21 topic
- Terpenoid Biosynthesis21 topic
- Ubiquitin21 topic
Where does Naomi Ohbayashi work?
Naomi Ohbayashi's main affiliation in the publication record is IRYO Sosei University, Japan.
How many publications and citations does Naomi Ohbayashi have?
OpenAlex counts 18 works and 481 citations for Naomi Ohbayashi, an h-index of 11, ranking #5,217,222 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Naomi Ohbayashi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.